1. Tait, D L, Obermiller, P S, Jensen, R A, Holt, J T. . Ovarian cancer gene therapy. In Hematology/oncology clinics of North America, 12, 539-52. doi:. https://pubmed.ncbi.nlm.nih.gov/9684097/
2. He, Guozhang, Ni, Yuanting, Hua, Rong, Liang, Hong, Chen, Ming. 2024. Latexin deficiency limits foam cell formation and ameliorates atherosclerosis by promoting macrophage phenotype differentiation. In Cell death & disease, 15, 754. doi:10.1038/s41419-024-07141-3. https://pubmed.ncbi.nlm.nih.gov/39424784/
3. Li, Yaping, Huang, Baohua, Yang, Hua, Shu, Wei, Chen, Ming. 2020. Latexin deficiency in mice up-regulates inflammation and aggravates colitis through HECTD1/Rps3/NF-κB pathway. In Scientific reports, 10, 9868. doi:10.1038/s41598-020-66789-x. https://pubmed.ncbi.nlm.nih.gov/32555320/
4. Cui, Xiaojing, Zhang, Cuiping, Wang, Fang, Tong, Sheng, Liang, Ying. 2023. Latexin regulates sex dimorphism in hematopoiesis via gender-specific differential expression of microRNA 98-3p and thrombospondin 1. In Cell reports, 42, 112274. doi:10.1016/j.celrep.2023.112274. https://pubmed.ncbi.nlm.nih.gov/36933218/
5. Muthusamy, Viswanathan, Premi, Sanjay, Soper, Cara, Platt, James, Bosenberg, Marcus. 2013. The hematopoietic stem cell regulatory gene latexin has tumor-suppressive properties in malignant melanoma. In The Journal of investigative dermatology, 133, 1827-33. doi:10.1038/jid.2013.48. https://pubmed.ncbi.nlm.nih.gov/23364479/
6. Liang, Ying, Jansen, Michael, Aronow, Bruce, Geiger, Hartmut, Van Zant, Gary. 2007. The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice. In Nature genetics, 39, 178-88. doi:. https://pubmed.ncbi.nlm.nih.gov/17220891/